UnknownNot Applicable

Laser Therapy in Managing Vaginal Prolapse

Greece30 participantsStarted 2018-11-30

Plain-language summary

Efficacy of laser therapy in postmenopausal women with symptomatic prolapse stage \>1. Assessment tools will include prolapse stage quantification system (POP-Q) and validated condition related questionnaires.

Who can participate

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Symptomatic prolapse stage \>1 (cystocele, vaginal vault prolapse, enterocele, rectocele) according to POP-Q System * Negative Pap-smear Exclusion Criteria: * Asymptomatic prolapse * prolapse stage \<=1 * prolapse of uterus * presence of any type of genital infections (i.e herpes, vaginitis etc) * vaginal bleeding * underlying pathologies that could interfere in patients compliance (i.e psychiatric)

What they're measuring

Pelvic Organ Prolapse Quantification System (POP-Q)

Timeframe: Change from baseline to 4-6 months

Trial details

NCT IDNCT03714607

SponsorNational and Kapodistrian University of Athens

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-12

View on ClinicalTrials.gov More Cystocele trials